CIBC World Market
SRPT icon

CIBC World Market’s Sarepta Therapeutics SRPT Stock Holding History

CIBC World Market’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,626
Closed -$930K – 1331
2020
Q3 		$930K Buy
+6,626
New +$1.01M ﹤0.01% 664
2016
Q3 		– Sell
-27,745
Closed -$529K – 1052
2016
Q2 		$529K Sell
27,745
-1,390
-5% -$25.7K ﹤0.01% 651
2016
Q1 		$569K Sell
29,135
-16,200
-36% -$283K ﹤0.01% 587
2015
Q4 		$1.75M Sell
45,335
-3,565
-7% -$116K 0.01% 359
2015
Q3 		$1.57M Buy
48,900
+29,000
+146% +$984K 0.01% 353
2015
Q2 		$606K Buy
+19,900
New +$407K ﹤0.01% 610

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIBC World Market's SRPT Position: Q4 2020 in Review

CIBC World Market sold out of Sarepta Therapeutics (SRPT) in Q4 2020, closing a stake of 6,626 shares — an estimated $930K sold.

CIBC World Market first reported a position in SRPT in Q2 2015 and held it in 6 quarters. The position peaked at $1.75M in Q4 2015. 454 funds tracked by Wall St. Rank hold SRPT as of Q4 2020.

  • CIBC World Market reported no remaining Sarepta Therapeutics position as of Q4 2020 after selling out during the quarter.
  • CIBC World Market sold 6,626 Sarepta Therapeutics shares in Q4 2020, an estimated $930K.
  • CIBC World Market first reported a position in Sarepta Therapeutics in Q2 2015 and held it in 6 quarters.
  • CIBC World Market's Sarepta Therapeutics position peaked at $1.75M in Q4 2015.
  • 454 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2020.

Based on CIBC World Market's 13F filing for Q4 2020, filed 8 Feb 2021.